This brand name is authorized in Australia, Austria, Brazil, Croatia, Cyprus, Ecuador, Estonia, France, Hong Kong SAR China, Ireland, Israel, Japan, Lithuania, Malta, Mexico, Netherlands, New Zealand, Poland, Romania, Singapore, South Africa, Spain, Tunisia, UK.
The drug UTROGESTAN contains one active pharmaceutical ingredient (API):
1
|
UNII
4G7DS2Q64Y - PROGESTERONE
|
|
Progesterone is a natural progestogen, the main hormone of the corpus luteum and the placenta. It acts on the endometrium by converting the proliferating phase to the secretory phase. |
|
Below package inserts are available for further reading:
| Document | Type | Information Source | |
|---|---|---|---|
| UTROGESTAN Capsule | MPI, EU: SmPC | Medicines & Healthcare Products Regulatory Agency (GB) |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC Group | Classification | |
|---|---|---|
| G03DA04 | Progesterone | G Genito urinary system and sex hormones → G03 Sex hormones and modulators of the genital system → G03D Progestogens → G03DA Pregnen (4) derivatives |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| AU | Pharmaceutical Benefits Scheme | 10930G, 12598C |
| BR | Câmara de Regulação do Mercado de Medicamentos | 542213020000014, 542213020000114, 542215030000603 |
| EC | Agencia Nacional de Regulación, Control y Vigilancia Sanitaria | 1581-MEE-1215, 1582-MEE-1215, 29625-02-11 |
| EE | Ravimiamet | 1703944, 1781715, 1781726, 1809660, 1818671, 1823318, 1847370, 1847381, 1849877 |
| ES | Centro de información online de medicamentos de la AEMPS | 60814, 64899 |
| FR | Base de données publique des médicaments | 61673424, 63157698 |
| GB | Medicines & Healthcare Products Regulatory Agency | 117590, 226768 |
| HK | Department of Health Drug Office | 34020, 61091 |
| HR | Agencija za lijekove i medicinske proizvode | HR-H-677297904, HR-H-957395225, HR-H-979088283 |
| IE | Health Products Regulatory Authority | 58492 |
| IL | מִשְׂרַד הַבְּרִיאוּת | 2902, 4728 |
| JP | 医薬品医療機器総合機構 | 2477700H1020 |
| LT | Valstybinė vaistų kontrolės tarnyba | 1090521, 1090522 |
| MT | Medicines Authority | MA727/00205, MA727/00501, PI1438/00701A, PI908/22301A |
| MX | Comisión Federal para la Protección contra Riesgos Sanitarios | 188M93 |
| NL | Z-Index G-Standaard, PRK | 198366, 29181 |
| NZ | Medicines and Medical Devices Safety Authority | 13679, 17513 |
| PL | Rejestru Produktów Leczniczych | 100412142, 100458655, 100462951, 100468073, 100468731 |
| RO | Agenția Națională a Medicamentului și a Dispozitivelor Medicale | W12320001, W42276001, W42276002, W42276003, W42276004 |
| SG | Health Sciences Authority | 11437P, 15475P |
| TN | Direction de la Pharmacie et du Médicament | 5173031, 5173032 |
| ZA | Health Products Regulatory Authority | 29/21.8.2/0215, A40/21.8.2/0771 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.